LCTX Retained Earnings

Lineage Cell Therapeutics, Inc. Common Stock · Retained Earnings

LCTX logo

LCTX Retained Earnings

Latest reported-$467.00M
LCTX FY Retained Earnings (-$1.00M → -$467.00M)
High-resolution chart · PNG

LCTX retained earnings history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
-466,998,000
-403,465,000
-384,856,000
-363,370,000
-337,097,000
-294,078,000
-273,422,000
-261,856,000
-216,297,000
-196,321,000
-229,181,000
-182,190,207
-145,778,547
-101,895,712
-80,470,009
-63,954,509
-52,769,891
-47,625,392
-43,844,497
-42,406,271
-40,541,650
-38,467,399
-35,382,075
-33,640,000
-30,795,069
-27,136,244
-22,211,220
-16,700,000
-12,800,000
-8,100,000
-6,100,000
-3,700,000
-2,200,000
-1,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.